Haleon releases first earnings since GSK spin off, rebuffs Zantac claims

Haleon released its first earnings report since its split from GSK over the summer.

The newly independent company reported revenue growth of 13.4% in H1 2022, totaling £5.19 billion. Haleon’s reported operating profit in the first half of the year increased 22.1% to £900 million, while net cash from operating activities hit £680 million.